Cassyni Biopharma reposted this
We thank Pharma Tech Outlook and all experts who voted Antharis Therapeutics, Inc. as one of the top 10 biotech startup companies of 2023. We are grateful for the recognition of our team’s hard work and dedication, and take this opportunity to reaffirm our commitment to advance the next generation of monoclonal antibodies directed at unmet medical needs. We are especially thankful for the leadership and strategic guidance of our CEO & Chairman, Raphael R Pinaud, PhD, MBA, as well as the scientific leadership, collaborative spirit and vision of Eric Sjoberg and Jinming Xia, Ph.D. . Ad astra!